Key Sessions
Kathryn Beal, Ph.D.
Enhanced Rational Expression Vector Design to Maximize the Performance of our Dual Site-Specific Integration CHO Host System
Pfizer, Inc.
Cindy Chelius, Ph.D.
Adaptive Process Control Using Biocapacitance Probes in Mammalian Fed-Batch Cell Culture for Improved Process Robustness from Bench-top to Pilot Scale
Bristol Myers Squibb
Yuanyuan Cui, Ph.D.
Models, Data, and Mindset: Building the Digital Twin Journey from Offline Insights to Real-Time Control
Sanofi
David Scherr, Ph.D.
10-fold Improvement in Depth Filter Capacity through Cycling Operation during Integrated Dynamic Bioprocessing (IDB) purification
AstraZeneca
Carlos Arbelaez
Panel Discussion: Future Directions – Making Cell & Gene Therapies More Accessible and Attractive
Johnson & Johnson
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Tuesday March 10 - PT (Pacific Time, GMT-08:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Formats
Tuesday March 10 - PT (Pacific Time, GMT-08:00)
search
Streams
Clear
Formats
Showing 1 of 1 Streams
Manufacturing Strategy & Bioprocessing 4.0
8:55am - 9:00am
Chairperson's Opening Remarks: Manufacturing Strategy & Bioprocessing 4.0
- Christoph Herwig - Senior Scientific Advisor, Körber Pharma Austria GmbH, Austria
9:00am - 9:30am
Multi Objective Optimization of Single Steps and Complete Process Chains using AI-based digital twins
- Christoph Herwig - Senior Scientific Advisor, Körber Pharma Austria GmbH, Austria
9:30am - 10:00am
Biopharmaceutical Manufacturing Optimization with a Factory Digital Twin
- Joseph Pekny - Professor, Chemical Engineering, Purdue University
10:00am - 10:30am
Defining Digital Twins in a Biomanufacturing Environment
- James Bornholdt - Ecosystem Executive, Process Manufacturing, Autodesk
- Vicki Pearson - Strategic Marketing Manager, Schneider Electric
Showing 1 of 1 Streams
Manufacturing Strategy & Bioprocessing 4.0
11:15am - 11:45am
Smarter Bioprocessing: Differentiating ML and AI for Process Optimization – Industrial Use Cases and Implementation Paths
- Maximilian Krippl, Ph.D. - Head of Consulting, Novasign GmbH
11:45am - 12:15pm
Panel Discussion: Modernizing Quality Through Risk Based Approaches
- Cassidy Cantin - Associate Partner, Latham BioPharm Group, Sia/LBGLatham
- Dawn Speidel - Vice President, Inventprise
- Dianne Cantara - Associate Manager, Latham BioPharm Group, part of Sia Partners
- Ben Mills - Senior Director, Operations (Joint Audit Program/Quality), Rx-360
Showing 1 of 1 Streams
Manufacturing Strategy & Bioprocessing 4.0
1:55pm - 2:00pm
Chairperson's Remarks
- Mia Wang - Senior Director, CMC Team Leader, Gilead
2:00pm - 2:30pm
High Concentration Antibody Products (HCAPs) to Enable IV to SC Shift: Current Status
- Ramesh Kashi, Ph.D. - Senior Scientific Advisor - Biologics Development, former Senior Scientific Director, Bristol Myers Squibb
3:00pm - 3:30pm
Pharma Risk Tolerance in AI Usage
- Joshua Speidel, Ph.D. - Managing Director, Commercial Practice Lead, Latham BioPharm Group, Inc., PMP
- Stephanie Pasas-Farmer, Ph.D. - President and Founder, BioData Solutions, LLC
Showing 1 of 1 Streams
Manufacturing Strategy & Bioprocessing 4.0
4:15pm - 4:45pm
Models, Data, and Mindset: Building the Digital Twin Journey from Offline Insights to Real-Time Control
- Digital Twin integrates data, models, and process understanding from development through GMP manufacturing.
- Transitioning from post-run analysis to live predictive monitoring and control closes the loop between insight and action.
- Robust data integrity, model validation, and lifecycle management enable regulatory readiness and trust.
- Building model literacy and cross-functional collaboration across R&D, MSAT, QA, and Operations to ensure sustainable technology adoption and culture alignment.
- Yuanyuan Cui, Ph.D. - DSD Modeling Manager, Sanofi
4:45pm - 5:15pm
The Self-Driving Lab: GenAI Takes the Wheel of Lab Robotics, Agents Step on the Gas
Lab robotics are currently impaired from realizing their true potential to be zero-touch, high-throughput, tireless machines. Automation specialists, software developers, and scientists must work together for months to stand-up workflows that still need constant monitoring. At Genentech, we are working on this digital transformation challenge by experimenting with LLMs to translate 'traditional' protocols into machine-executable instructions and AI agents to orchestrate complex workflows. In this talk, I'd like to share our progress and ideas for how lab robotics can be unleashed to democratize automated experiments, ensure better error recovery, and execute workflows across different labs and instruments on demand.
- Aleksandra (Sasha) Denisin, Ph.D. - Principal Product Manager for Automation, Data and Solutions Engineering, Genentech, Inc.
5:15pm - 5:45pm
Panel Discussion: Bioprocessing 4.0 – Making Digital Transformation a Reality
- Christoph Herwig - Senior Scientific Advisor, Körber Pharma Austria GmbH, Austria
- Jinghan Li - Applications Scientist, Croda Inc.
- Mia Wang - Senior Director, CMC Team Leader, Gilead
- Aleksandra (Sasha) Denisin, Ph.D. - Principal Product Manager for Automation, Data and Solutions Engineering, Genentech, Inc.
- Hannes Bretschneider, Ph.D. - Chief AI Officer, Katalyze AI
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear
Formats
